Advancing preclinical research and finding the right trial participants, especially with rare or complex conditions, remains a key challenge. AI-powered tools are helping close the bench to bedside gap by streamlining data and speeding up patient identification. Aaron Brauser, president and cofounder of Realyze Intelligence (a Carta Healthcare company), shares how better data sharing and collaboration can drive progress in Drug Discovery & Development. ➡️ https://bit.ly/3DR9M4x | #ClinicalTrials #AIinHealthcare #PatientRecruitment #ClinicalDataManagement
